Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA

Sandra M Tapiero-Rodriguez,1 Johanna C Acosta Guio,1 Gloria Liliana Porras-Hurtado,2 Natalia García,3 Martha Solano,4 Harry Pachajoa,5 Harvy M Velasco1 1Universidad Nacional de Colombia, Departamento de morfología, Maestría de genética humana, Bogot&aa...

Full description

Bibliographic Details
Main Authors: Tapiero-Rodriguez SM, Acosta Guio JC, Porras-Hurtado GL, García N, Solano M, Pachajoa H, Velasco HM
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:The Application of Clinical Genetics
Subjects:
Online Access:https://www.dovepress.com/determination-of-genotypic-and-clinical-characteristics-of-colombian-p-peer-reviewed-article-TACG
_version_ 1811323204984111104
author Tapiero-Rodriguez SM
Acosta Guio JC
Porras-Hurtado GL
García N
Solano M
Pachajoa H
Velasco HM
author_facet Tapiero-Rodriguez SM
Acosta Guio JC
Porras-Hurtado GL
García N
Solano M
Pachajoa H
Velasco HM
author_sort Tapiero-Rodriguez SM
collection DOAJ
description Sandra M Tapiero-Rodriguez,1 Johanna C Acosta Guio,1 Gloria Liliana Porras-Hurtado,2 Natalia García,3 Martha Solano,4 Harry Pachajoa,5 Harvy M Velasco1 1Universidad Nacional de Colombia, Departamento de morfología, Maestría de genética humana, Bogotá, 2Family Compensation Fund of Risaralda, Pereira, 3Faculty of Medicine, Manizales University, Manizales, 4Department of Neuropediatrics, Cardioinfantil Foundation, Bogotá, 5Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras, Universidad ICESI y Fundación Valle del Lili, Cali, Colombia Background: As mucopolysaccharidosis IVA (MPS IVA) is the most frequent MPS in Colombia, this paper aims to describe its clinical and mutational characteristics in 32 diagnosed patients included in this study. Methods: Genotyping was completed by amplification and Sanger sequencing of the GALNS gene. The SWISS-model platform was used for bioinformatic analysis, and mutant proteins were generated by homology from the wild-type GALNS code 4FDI template from the Protein Data Bank (PDB) database. Docking was performed using the GalNAc6S ligand (PubChem CID: 193456) by AutoDock Vina 1.0 and visualized in PyMOL and LigPlot+. Results: Eleven variants were identified, and one new pathogenic variant was described in the heterozygous state, which is consistent with genotype c. 319 G>T or p.Ala107Ser. The pathogenic variant c.901G>T or p.Gly301Cys was the most frequent mutation with 51.6% of alleles. Docking revealed affinity energy of −5.9 Kcal/mol between wild-type GALNS and the G6S ligand. Some changes were evidenced at the intermolecular interaction level, and affinity energy for each mutant decreased. Conclusion: Clinical variables and genotypic analysis were similar to those reported for other world populations. Genotypic data showed greater allelic heterogeneity than those previously reported. Bioinformatics tools showed differences in the binding interactions of mutant proteins with the G6S ligand, in regard the wild-type GALNS. Keywords: mucopolysaccharidosis IVA, Morquio syndrome, GALNS, lysosomal storage disorder, mutation
first_indexed 2024-04-13T13:50:55Z
format Article
id doaj.art-3bf4880d6a114cfda310ce4a9f1487e0
institution Directory Open Access Journal
issn 1178-704X
language English
last_indexed 2024-04-13T13:50:55Z
publishDate 2018-04-01
publisher Dove Medical Press
record_format Article
series The Application of Clinical Genetics
spelling doaj.art-3bf4880d6a114cfda310ce4a9f1487e02022-12-22T02:44:21ZengDove Medical PressThe Application of Clinical Genetics1178-704X2018-04-01Volume 11455737943Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVATapiero-Rodriguez SMAcosta Guio JCPorras-Hurtado GLGarcía NSolano MPachajoa HVelasco HMSandra M Tapiero-Rodriguez,1 Johanna C Acosta Guio,1 Gloria Liliana Porras-Hurtado,2 Natalia García,3 Martha Solano,4 Harry Pachajoa,5 Harvy M Velasco1 1Universidad Nacional de Colombia, Departamento de morfología, Maestría de genética humana, Bogotá, 2Family Compensation Fund of Risaralda, Pereira, 3Faculty of Medicine, Manizales University, Manizales, 4Department of Neuropediatrics, Cardioinfantil Foundation, Bogotá, 5Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras, Universidad ICESI y Fundación Valle del Lili, Cali, Colombia Background: As mucopolysaccharidosis IVA (MPS IVA) is the most frequent MPS in Colombia, this paper aims to describe its clinical and mutational characteristics in 32 diagnosed patients included in this study. Methods: Genotyping was completed by amplification and Sanger sequencing of the GALNS gene. The SWISS-model platform was used for bioinformatic analysis, and mutant proteins were generated by homology from the wild-type GALNS code 4FDI template from the Protein Data Bank (PDB) database. Docking was performed using the GalNAc6S ligand (PubChem CID: 193456) by AutoDock Vina 1.0 and visualized in PyMOL and LigPlot+. Results: Eleven variants were identified, and one new pathogenic variant was described in the heterozygous state, which is consistent with genotype c. 319 G>T or p.Ala107Ser. The pathogenic variant c.901G>T or p.Gly301Cys was the most frequent mutation with 51.6% of alleles. Docking revealed affinity energy of −5.9 Kcal/mol between wild-type GALNS and the G6S ligand. Some changes were evidenced at the intermolecular interaction level, and affinity energy for each mutant decreased. Conclusion: Clinical variables and genotypic analysis were similar to those reported for other world populations. Genotypic data showed greater allelic heterogeneity than those previously reported. Bioinformatics tools showed differences in the binding interactions of mutant proteins with the G6S ligand, in regard the wild-type GALNS. Keywords: mucopolysaccharidosis IVA, Morquio syndrome, GALNS, lysosomal storage disorder, mutationhttps://www.dovepress.com/determination-of-genotypic-and-clinical-characteristics-of-colombian-p-peer-reviewed-article-TACGMucopolysaccharidosis IVAMorquio syndromeGALNSlysosomal storage disordermutation.
spellingShingle Tapiero-Rodriguez SM
Acosta Guio JC
Porras-Hurtado GL
García N
Solano M
Pachajoa H
Velasco HM
Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
The Application of Clinical Genetics
Mucopolysaccharidosis IVA
Morquio syndrome
GALNS
lysosomal storage disorder
mutation.
title Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
title_full Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
title_fullStr Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
title_full_unstemmed Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
title_short Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
title_sort determination of genotypic and clinical characteristics of colombian patients with mucopolysaccharidosis iva
topic Mucopolysaccharidosis IVA
Morquio syndrome
GALNS
lysosomal storage disorder
mutation.
url https://www.dovepress.com/determination-of-genotypic-and-clinical-characteristics-of-colombian-p-peer-reviewed-article-TACG
work_keys_str_mv AT tapierorodriguezsm determinationofgenotypicandclinicalcharacteristicsofcolombianpatientswithmucopolysaccharidosisiva
AT acostaguiojc determinationofgenotypicandclinicalcharacteristicsofcolombianpatientswithmucopolysaccharidosisiva
AT porrashurtadogl determinationofgenotypicandclinicalcharacteristicsofcolombianpatientswithmucopolysaccharidosisiva
AT garcian determinationofgenotypicandclinicalcharacteristicsofcolombianpatientswithmucopolysaccharidosisiva
AT solanom determinationofgenotypicandclinicalcharacteristicsofcolombianpatientswithmucopolysaccharidosisiva
AT pachajoah determinationofgenotypicandclinicalcharacteristicsofcolombianpatientswithmucopolysaccharidosisiva
AT velascohm determinationofgenotypicandclinicalcharacteristicsofcolombianpatientswithmucopolysaccharidosisiva